Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R De Maria

Showing results (151-160 of 155) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 155 results.
Expert Review of Vaccines|April 12, 2016
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studiesP Vici, L Pizzuti, L Mariani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2020
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burdenD Marinelli, M Mazzotta, S Scalera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2022
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinomaS Scalera, B Ricciuti, M Mazzotta, et al.
Cell Death and Differentiation|April 18, 2009
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotesL Galluzzi, S A Aaronson, J Abrams, et al.
Cell Death and Differentiation|September 20, 2014
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015L Galluzzi, J M Bravo-San Pedro, I Vitale, et al.
Pageof 16

Showing results (151-160 of 155) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 155 results.
Expert Review of Vaccines|April 12, 2016
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studiesP Vici, L Pizzuti, L Mariani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2020
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burdenD Marinelli, M Mazzotta, S Scalera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2022
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinomaS Scalera, B Ricciuti, M Mazzotta, et al.
Cell Death and Differentiation|April 18, 2009
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotesL Galluzzi, S A Aaronson, J Abrams, et al.
Cell Death and Differentiation|September 20, 2014
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015L Galluzzi, J M Bravo-San Pedro, I Vitale, et al.
Pageof 16